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Accurate measurement of adherence is necessary to ensure that therapeutic outcomes can
be attributed to the recommended treatment. Phone-based unannounced pill counts were
shown to be feasible and reliable measures of adherence in developed settings; and have
been further used as part of medication adherence interventions. However, it is not clear
whether this method can be implemented successfully in resource-limited settings, where
cellular network and mobile phone coverage may be low. Our objective is to describe opera-
tional issues surrounding the use of phone-based unannounced pill counts in Lesotho and
Ethiopia.
Methods
Phone-based monthly unannounced pill counts, using an adaptation of a standardized pro-
tocol from previous US-based studies, were utilized to measure anti-TB and antiretroviral
medication adherence in two implementation science studies in resource-limited settings,
START (Lesotho) and ENRICH (Ethiopia).
Results
In START, 19.6% of calls were completed, with 71.9% of participants reached at least once;
majority of failed call attempts were due to phones not being available (54.8%) or because
participants were away from the pills (32.7%). In ENRICH, 33.5% of calls were completed,
with 86.7% of participants reached at least once; the main reasons for failed call attempts
were phones being switched off (31.5%), participants not answering (27.3%), participants’
discomfort speaking on the phone (15.4%), and network problems (13.2%). Structural,
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settings.
Discussion
Phone-based unannounced pill counts were found to be challenging, and response rates
suboptimal. While some of these challenges were specific to local contexts, most of them
are generalizable to resource-limited settings. In a research study context, a possible solu-
tion to ease operational challenges may be to focus phone-based unannounced pill count
efforts on a randomly selected sample from participants who are provided with study phones
and rigorously ensure that call attempts are made for these participants.
Introduction
It is well-recognized that the promise of efficacious therapies to treat and prevent long-term
conditions cannot be met unless patients consistently adhere to prescribed regimens [1]. Medi-
cation adherence influences individual health outcomes, the cost of healthcare and, in the case
of communicable infections, can influence transmission and the emergence of resistant strains.
In clinical settings, accurate measurement of adherence is necessary to inform interpretation
of treatment response and identify individuals in need of enhanced adherence support. In
research settings, accurate measurement of adherence is necessary to ensure that therapeutic
outcomes can be attributed to the assigned treatment, especially when an intervention effect is
determined based on adherence. Unfortunately, accurate adherence measurement and moni-
toring remain significant challenges in both clinical and research settings.
In lieu of a single “gold standard” for measuring adherence [1], several direct and indirect
measurement methods were developed. The ideal methods for measuring adherence vary
depending on the setting and purpose of measuring adherence [2, 3]. Direct methods are gen-
erally more objective, yielding more reliable adherence assessments, but all methods have limi-
tations. Electronic monitoring devices have been recommended to collect detailed adherence
information but their use is limited by cost and risk of malfunction [3]. Pill counting is consid-
ered more feasible, and when used to measure antiretroviral adherence, it has been associated
with viral suppression [4–7]. Some studies, however, failed to demonstrate an association
between pill counts and viral load change [8]. Inaccuracies in clinic-based pill counts primarily
stem from patients failing to bring their pills to the clinic, as well as emptying pill containers
("pill dumping”) prior to the appointment [9]. Bangsberg et al developed a home-based unan-
nounced pill counting procedure, which reduces the opportunity to “pill dump”, because
patients do not know the time of pill counts in advance [10]. Home-based unannounced pill
counts virtually eliminate the potential problems faced by clinic-based pill counts, correlate
with electronic medication monitoring [11, 12], and predict changes in viral load over time
[10, 13].
Logistics and cost are major limitations of home-based unannounced pill counts. Unan-
nounced home visits are often met with unanswered doors and concerns of privacy and
confidentiality due to stigma. Additionally, these visits are logistically challenging and time-
consuming in rural areas. To increase utility and reduce costs, Kalichman and colleagues
adapted and tested a phone-based unannounced pill count protocol [14]. Phone-based unan-
nounced pill counts were shown to be feasible and reliable measures of adherence in developed
settings [14–18]; and have been further used as part of medication adherence interventions
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[19]. However, it is not clear whether this method can be implemented successfully in
resource-limited settings, where cellular network and mobile phone coverage may be low. As
part of the START (Start TB patients on ART and Retain on Treatment) and ENRICH
(ENhance initiation and Retention in IPT Care for HIV) implementation science studies, we
employed phone-based monthly unannounced pill counts to measure anti-tuberculosis (TB)
and antiretroviral medication adherence. Our objective is to describe operational issues sur-
rounding the use of phone-based unannounced pill counts in resource-limited settings.
Materials and methods
START and ENRICH methods, including settings and facility characteristics, have been
described elsewhere [20–22]. In brief, the START Study (ClinicalTrials.gov NCT01872390) is a
cluster-randomized trial which evaluated the effectiveness, cost-effectiveness and acceptability of
a combination intervention package (CIP) versus standard of care (SOC), to improve early anti-
retroviral therapy (ART) initiation, retention, and TB treatment success, among HIV-positive
TB patients at 12 health facilities in Berea District, Lesotho, a nation with an HIV prevalence of
25% [23] and a TB incidence rate of 788 per 100,000 [24]. The ENRICH Study (ClinicalTrials.
gov NCT01926379) is a cluster-randomized trial which evaluated the effectiveness of a CIP vs.
SOC, to improve isoniazid preventive therapy (IPT) initiation, adherence, and completion
among HIV-positive patients newly enrolled in HIV care at 10 health centers in Dire Dawa and
Harari, Ethiopia, a nation with close to 800,000 people with HIV [25] and a TB incidence rate of
192 per 100,000 [24]. The follow-up period in both studies was six months.
Research Assistants (RA) received training on the unannounced pill count procedure and
were provided with study phones to implement the pill counts. In both studies, monthly
phone-based unannounced pill counts were conducted with all participants in both study
arms. Pill counts were completed using an adaptation of a standardized protocol from previous
studies [14], whereby participants were called at undisclosed times between monthly visits and
asked to count their pills (S1 and S2 Files). Participants were not compensated for the pill
count calls. At the baseline study visit, participants were trained to count their medications
after answering the phone. In advance of the call, the RA recorded the name, dispense date,
number of pills dispensed, number of doses per day, and number of pills per dose for each
medication. Before proceeding with the pill counts, the RA first confirmed participants were
in a private area and had access to their pills. The RA recorded the date, whether pills were
taken before the call, and for each medication, how many pills were left. If a participant did
not answer the call, the RA did not leave a message and attempted to reach the participant
until the pill counts were completed, or five attempts have been made within the same month
without answer or pill counts completion. The original study protocols called for three call
attempts, but that was determined to be insufficient and after 15 and 12 months follow-up for
START and ENRICH respectively, the number of attempts was increased to five. If the partici-
pant requested that the RA call back at another time, the RA did not schedule the callback at a
specific time in order to maintain the pill count as ‘unannounced’.
We systematically collected quantitative and qualitative data on reasons for pill counts non-
completion from study records, through weekly pill count completion reports submitted by
RA (including attempt date, outcome, and if unsuccessful, the reason why), and conversations
between RA and participants during study visits. Reasons for non-completed counts were
recorded as open-ended responses that were later coded and categorized by the study investi-
gators as network problems, numeracy issues, not having a phone, lack of privacy for the call,
phone answered by someone other than the study participant, or not having pills at the time of
the call. Qualitative data were analyzed using Microsoft Excel. Quantitative analyses were
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conducted using SAS 9.4 (SAS Institute Inc., Cary, NC). Participant characteristics and call
outcomes were summarized with descriptive statistics using means, medians, proportions, and
Pearson’s χ2.
In Lesotho, mobile phone ownership was high (86 and 102 mobile cellular subscriptions
per 100 people in 2013 and 2014 respectively [26]); therefore, we did not distribute mobile
phones to participants. However in Ethiopia, mobile phone ownership was much lower (27
and 32 per 100 people in 2013 and 2014, respectively [26]), and as the ENRICH study interven-
tion included provision of adherence support messages to patients on IPT using interactive
voice response technology, we distributed inexpensive mobile phones to participants in the
CIP arm. Participants received a study-issued mobile phone, SIM card, and six months’ air-
time vouchers at an approximate total cost of USD 45 per patient. Landlines in the home are
practically nonexistent in the study locations, thus mobile phones were used exclusively to
reach participants for pill counts.
All procedures performed in these studies were in accordance with the ethical standards of
the institutional and/or national research committee and with the 1964 Helsinki Declaration
and its later amendments or comparable ethical standards. The START Study was approved by
the Columbia University Medical Center Institutional Review Board (CUMC-IRB) (Ref
#IRB-AAAK7103) and Lesotho’s National Health Institutional Review Board and Ethics
Research Committee (Ref #ID68-2012). The ENRICH Study was approved by the CUMC-IRB
(Ref #IRB-AAAK3163) and the National Research Ethics Review Committee in Ethiopia (Ref
#3.10/780/06). Informed consent was obtained from all individual participants included in the
studies. Participants were informed that monthly phone-based unannounced pill counts will
be conducted as part of the informed consent process.
Results
START enrolled 371 participants, who were followed up for a median of 4.8 months; 2831 calls
to 334 participants were attempted and 554 (19.6%) calls were completed. Attempts were not
made for 37 (10%) participants who didn’t have a phone (n = 25) or could be contacted after
hours only (n = 12). Participant characteristics are shown in Table 1. Overall, 240/334 (71.9%)
START participants were reached at least once. The mean (±standard deviation [SD]) number
of attempts per participant each month was 1.9±1.0. Completeness of calls was slightly higher
during months 1 and 2 of follow-up at 24.8% and 25.6%, respectively; calls attempted during
months 3–6 were completed 14.6%-17.9% of the time. Success rates were similar across study
arms (21.0% vs. 18.8%, p = 0.17) and significantly higher for females than males (23.2% vs.
16.6%, p<0.001).
ENRICH enrolled 316 participants, who were followed up for a median of 4.7 months; 3156
calls to 309 participants were attempted and 1058 (33.5%) calls were completed. Attempts
were not made for 7 (2%) participants in the SOC study arm who didn’t have a phone
(Table 1). Overall, 268/309 (86.7%) ENRICH participants were reached at least once. The
mean (±SD) number of attempts per participant for each month was 2.1±1.4. Completeness of
monthly calls was fairly consistent but declined from 36.6% in month 1 to 30.2% in month 6.
Success rates were higher at CIP than SOC sites (38.4% vs. 27.2%, p<0.001); reasons differed
by arm (p<0.001). SOC sites had a higher proportion of failed calls recorded as resulting from
the patient having no phone (8.4% vs 1.5%, p< .0001) or being due to network problems
(19.0% vs 7.7%, p< .0001). The most common reason for failure in the CIP arm was the
phone was switched off (32.9%) followed by the phone was not answered (31.6%). Success
rates did not differ between male and female participants.
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As shown in Table 2, the majority of failed call attempts in START were due to the phone not
being available (54.8%) or because the participant was away from the pills (32.7%). In ENRICH,
the main reasons for failed call attempts were phone being switched off (31.5%), participants not
answering the phone (27.3%), or participants’ discomfort with speaking on the phone (15.4%).
Network problem was listed by the RA as the cause of failed calls 13.2% of the time.
Many challenges were encountered in implementation of phone-based unannounced pill
counts in these settings (Fig 1). In response, the respective study teams explored reasons for
these challenges through conversations with participants at monthly study visits, and devel-
oped solutions as challenges arose over the course of the studies.
Structural challenges
1. High phone ownership did not necessarily translate to high phone availability. Many partic-
ipants ran out of battery or kept phones turned off intentionally to preserve battery because
they were unable to recharge their phone regularly due to frequent power outages.
Table 2. Reasons for failed calls.
START ENRICH
N (%) N (%)
Phone not available 1038 (54.2%) 0 (0%)
Network problem 12 (0.6%) 262 (13.2%)
Participant has no phone 0 (0%) 97 (4.9%)
Phone switched off 0 (0%) 624 (31.5%)
Phone unanswered 215 (11.2%) 541 (27.3%)
Participant uncomfortable to talk 0 (0%) 304 (15.4%)
Phone picked up by someone else 20 (1.0%) 90 (4.5%)
Participant away from the pills 626 (32.7%) 0 (0%)
Other problem 5 (0.3%) 61 (3.1%)
https://doi.org/10.1371/journal.pone.0185549.t002
Table 1. Participant characteristics at baseline.
START ENRICH
N = 371a N = 316b
Age, median (IQR) 35 (30–44) 30 (26–38.5)
Female, n (%) 160 (43.1%) 200 (63.3%)
Marital status, n (%)
- Married/living together 202 (54.4%) 130 (41.1%)
- Divorced/widowed 98 (26.4%) 131 (41.5%)
- Never married/lived together 71 (19.1%) 55 (17.4%)
Head of household (sole/shared), n (%) 168 (46.0%) 237 (75.0%)
Education, n (%)
- None 29 (7.8%) 69 (21.8%)
- Primary 228 (61.5%) 159 (50.3%)
- Secondary or higher 114 (30.7%) 88 (27.9%)
Electricity in the home, n (%) 178 (48.0%) 239 (94.0%)
Own cell phone, n (%) 323 (87.1%) 220 (69.8%)
aColumn numbers may not sum to totals due to missing data. Percentages are provided among non-missing
data (n missing: age, 1; head of household, 6).
bColumn numbers may not sum to totals due to missing data. Percentages are provided among non-missing
data (n missing: own cell phone, 1).
https://doi.org/10.1371/journal.pone.0185549.t001
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2. In Lesotho many participants worked in neighboring South Africa or lived near the border
where network coverage is supplied by South African companies. As such, these partici-
pants often maintained a South African SIM card in their phone and were unreachable
when study staff called their Lesotho number.
3. There was poor network coverage within some areas of Lesotho and Ethiopia.
Attempted solutions
1. Participants were encouraged to bring their phones to the clinic so that they could charge
the battery during their study visit, but the battery did not necessarily last until the next
attempted unannounced pill count.
2. Participants were asked for their South African numbers and pill count attempts were
made using a prepaid mobile phone equipped to make international calls.
3. Study staff varied the times of day at which they attempted pill counts to increase the likeli-
hood of catching a participant when s/he might be traveling through or working in an area
with more reliable coverage, as well as asking the participant whether s/he might be reached
on other numbers.
Facility-level challenges
1. Although making calls on a variable basis is critical for increasing the validity of the counts,
it prevented staff from establishing a routine schedule.
2. Mismatch between participant availability and staff working hours, as some clinics closed
early afternoon, severely restricting access to study records to prepare for pill counts.
3. Some participants worked very long hours, and could not be reached even during extended
office hours. To protect participants’ confidentiality and ensure data integrity, research staff
could not remove study documents from the site, and thus could not make calls in the even-
ing or on the weekends.
Fig 1. Implementation challenges of phone-based unannounced pill counts in resource-limited settings.
https://doi.org/10.1371/journal.pone.0185549.g001
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Attempted solutions
1. In Lesotho, RA maintained a calendar to record pill count attempts, which assisted
them in tracking pill count completion and outstanding attempts, and assisted the
Study Coordinator in monitoring and ensuring call attempts were made. In Ethiopia, a
module in the study database reminded RA when calls were due, and enabled them to
log attempts.
2. The study team introduced some flexibility for study staff by staggering schedules and
allowing study calls to be made from the head office rather than study clinics.
3. Arrangements were made for conducting pill counts from home using a separate sheet of
paper and then transferring the information to the pill count forms in the office. Staff were
trained to safeguard against potential violations of confidentiality, and were instructed to
record only the minimum data required (i.e., participant name and phone number), to
record no study identifiers, and to destroy the take-home paper after transferring the infor-
mation to the study records.
Participant-level challenges
1. Many participants shared phones with other household members.
2. Some participants were at work and did not have access to pill bottles or did not feel free to
count them at work, due to the pervasive stigma.
3. While numeracy and facility with technology did not prove problematic in Lesotho,
which has an adult literacy rate of 90% and high cell phone ownership, these did pres-
ent significant challenges in Ethiopia, where only 39% of the adult population is liter-
ate [27]. Some participants were unable to count their pills independently and some
lacked confidence in using their phones, including entering their passcode to unlock
the phone.
Attempted solutions
1. The number of attempts was increased from three to five so that participants who shared
phones or were unable to count their pills at work were more likely to be reached.
2. Study staff were reminded to vary the times of day for pill count calls and to ask whether
there was a preferred period of time when they would generally be available for pill counts.
3. Study staff assisted participants with simplifying their mobile phone passcode and practiced
phone use and counting at study visits. If participants struggled to count when staff reached
them on the phone, RA asked whether there was someone who could assist.
Data collection challenges
Even if participants were reached and pill counts completed, challenges with knowing if a par-
ticipant refilled or changed medications between visits remained, as clinic staff occasionally
altered participants’ regimens between study visits in response to side effects or gave a larger
supply of pills prior to travelling for an extended period.
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Attempted solutions
Study staff encouraged participants to inform them whenever they came to the clinic at an
unscheduled time, continued reminding clinic staff about the study, and attempted to remain
visible and approachable in the clinics.
Discussion
To our knowledge, this is the first examination of the implementation of phone-based unan-
nounced pill counts in resource-limited settings. In our implementation science studies in
Lesotho and Ethiopia, phone-based unannounced pill counts were found to be challenging,
with response rates varying between 20% and 34% in the two studies. Structural, facility-level,
participant-level, and data collection challenges were encountered. While some challenges
were specific to the local context (e.g., migration between Lesotho and South Africa; low cell
phone ownership and literacy rates in Ethiopia), many are generalizable to resource-limited
settings. It is important to note that the main contributors to failed calls were availability of
phones, switched-off phones, and participants being away from the medicines. Many partici-
pants required as many as five calls to reach them, and many attempts did not result in success-
ful completion of pill counts. It is important to consider the possibility that participants did
not answer the phone when they recognized the study phone number because they could not,
or did not want to, perform the pill count. This may have also contributed to the declining pill
counts response rate over time. However, in these settings it’s not possible to have the caller
number displayed as ‘private caller’.
While phone-based pill counts can be conducted in urban and rural areas, and missed
phone contacts are inexpensive and allow staff to contact another participant without delay,
they are also staff-intensive. It is crucial to carefully consider the practicalities of pill counts
logistics, including the feasibility of making calls outside of normal work hours, and schedul-
ing and ensuring attempts are actually made. In an effort to minimize implementation chal-
lenges, we consulted with experienced researchers who have used this procedure, albeit in
developed settings, before study commencement. In a research study context, a possible solu-
tion to ease operational challenges may be to focus phone-based unannounced pill count
efforts on a randomly selected sample from participants who are provided with study phones
and rigorously ensure that up to five call attempts are made for these participants if they are
not reached sooner. This approach may mitigate the potential for possible Hawthorne effects
in two ways. First, the pill counts are unannounced and therefore participants do not know
when they might be contacted; and second, participants will be randomly selected and there-
fore not know whether or not they will be contacted.
Earlier research experiences in the US found phone-based unannounced pill counts to be a
feasible and reliable measure of medication adherence [14–17]. Among the greatest differences
between early experiences and ours are structural challenges, including lack of mobile phone
ownership, poor network availability, and participant mobility. Kalichman et al provided each
participant with a dedicated mobile phone to maximize reachability [14]. Eligibility criteria in
the study by Thompson et al included having a functioning phone [16]. As noted above,
mobile phone ownership was very high in Lesotho and we supplied mobile phones to CIP par-
ticipants in Ethiopia. Therefore, while phone ownership in our studies (except for SOC partici-
pants in Ethiopia) should have been comparable to prior studies, we suspect that unreliable
network coverage and limited availability of electricity to charge phone batteries significantly
impacted our participants’ ability to respond to calls. Kalichman et al found that 10/99 (10.1%)
participants were unreachable by any phone, including the dedicated study phone given to
them [15], compared to 94/334 (28.1%) of START participants and 41/309 (13.3%) of
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ENRICH participants. In a recent US study where participants were not provided with a
mobile phone, Fredericksen et al found high concordance for phone-based and home-based
unannounced pill counts [17]. The distribution of study mobile phones to CIP participants in
Ethiopia had the potential to facilitate phone-based unannounced pill counts; however, phone
use remained challenging in this setting. Surprisingly, when we compared response rates for
study participants in the SOC arms, i.e. participants who did not receive a study phone, we
found the response rate in Ethiopia to be higher than in Lesotho, which may be further indica-
tion that phone ownership does not guarantee good response. The relatively high level of
population mobility in Lesotho, particularly among Basotho men, also posed a unique impedi-
ment to the completion of pill counts, which may account for a significantly higher response
rate among females than males in Lesotho.
With respect to scheduling and management of the call attempts, we followed Kalichman
[14] in having RA complete a baseline assessment with participants indicating the days and
times which were most and least preferred to receive calls. Despite efforts to maximize the
likelihood of successful calls by calling during acceptable times, the number of attempts
required to reach our participants were similar to studies in developed settings. Kalichman
et al reported that 57% of participants were reached on the first attempt, 23% on the second
attempt, and 20% required3 attempts [14], while Thompson et al found that nearly half of
participants were contacted on the first attempt, with “the majority” being contacted by the
second attempt [16]. These studies do not indicate common reasons why participants were not
always reachable on the first or second attempt. Perhaps most notable is Fredericksen et al’s
report that approximately four attempts were made to call participants before successfully
reaching them [17]. Given the additional logistical and structural barriers present in resource-
limited settings, the initial protocol of three attempts was perhaps overly optimistic. Authors
of earlier studies do not provide details regarding human resources and call scheduling (e.g.,
whether a single staff member was dedicated to making calls, whether calls were attempted
outside working hours), both of which would seem likely to increase pill count completion
rates, but neither of which are likely to be feasible within public health systems in resource-
limited settings. Integrating special software that helps manage the scheduling of these calls,
such as maintaining a log of previous attempts and prompting additional attempts at given
times, may have helped with their implementation. Having staff dedicated exclusively to the
task of conducting unannounced pill counts might have alleviated some management and
scheduling challenges, but such arrangements would be difficult to integrate into the structure
of clinics in any future transition of implementation from research to clinic staff.
Participant confidence and competence in completing pill counts also offers a point of com-
parison. Kalichman et al report no participant was unable to count or required assistance,
although they acknowledged this does not preclude the possibility of miscalculation or mis-
identification of medications [15]. This caveat is particularly important to bear in mind for
populations with comorbidities, who are taking multiple medications. The major challenge
reported by Kalichman and colleagues was that of participants struggling to manage and orga-
nize the pill count procedure, and they suggested repeated training and rehearsal with partici-
pants to minimize this problem; this additional training was undertaken in our studies by RA,
village health workers (Lesotho), and peer educators (Ethiopia) to assist participants with the
use of phones and with counting. While our studies in Lesotho and Ethiopia found that partic-
ipants with low numeracy were in fact able to complete counts (contrary to prior expectations
[15]), ultimately larger structural and logistical barriers overshadowed the overall feasibility of
phone-based unannounced pill counts.
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Conclusion
Phone-based unannounced pill counts have proven challenging in two implementation sci-
ence studies in resource-limited settings, which may cast a shadow over their utility in assess-
ing adherence in research studies. However, in a research study context, a sample-based
ascertainment of adherence using phone-based unannounced pill counts may offer a feasible
solution to collecting adherence data in these settings.
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